Navigation Links
Early Liver Transplantation Regardless of Donor Type Increases Long-term Survival

Research to be presented Saturday, November 1, 2008 at this year's liver

meeting held in San Francisco, California, October 31-November 4

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- Researchers analyzed 43,497 patients on the UNOS waitlist for a liver transplantation and 22,863 adults who received transplantation to determine the best time strategy for transplantation. They concluded that the increase in posttransplant mortality caused by differences in donor type was vastly offset by the greater benefit in early access to transplantation regardless of donor type. According to Michael Goldstein, MD, principal investigator, "The study might affect thousands of patients since it may change the way in which we allocate organs."

UNOS uses the Mayo Model for End-Stage Liver Disease (MELD) score, a marker of disease severity to assess prognosis of patients with liver disease. According to Dr. Goldstein, "Percentage of patients who are on the transplant list who die before transplant varies by region but we estimate between 5% and 10%." Patients are usually added to the waitlist when they meet certain medical criteria for transplantation. MELD scores may vary at the time of listing, depending on the severity of illness and the timing of presentation to a transplant center. "Many other patients will not meet criteria for listing because of severity of disease and some will become inactive and die because of progression of cancer or unstable psychosocial situations," says Dr. Goldstein.

The researchers calculated the relative waitlist mortality and posttransplant survival for recipients who received living donor organs, as well as deceased donor organs that are both low and high donor risk index. They concluded that living donor and high donor risk index allografts offer the most benefit to those with a mid-Meld score (between 11 and 24) but is dependent on early timing of transplant and should be used early to decrease waitlist mortality. Speaking of the conclusions, Dr. Goldstein says, "We are not surprised by the findings. We have assumed this for some time in New York and live by these standards every day."

Dr. Goldstein concludes, "The real benefits to adopting new allocation strategies are to increase regional organ sharing for those areas most disadvantaged by the donor shortage. We can redistribute organs from areas with short waiting times to allow sick patients to be transplanted sooner in regions with little access to organs."

Abstract title:

Early access to liver transplantation reduces 5-year mortality despite differences in donor quality

AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting, held in San Francisco, California, October 31-November 4, will bring together more than 7,000 researchers from 55 countries.

A pressroom will be available from November 1 at the annual meeting. For copies of abstracts and press releases, or to arrange for pre-conference research interviews contact Gregory Bologna at 703-299-9766. To pre-register, call Ann Tracy at 703-299-9766.

Press releases and all abstracts are available online at

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Unique Way to Help Your Favorite Animal - Morris Animal Foundations 2009 Sponsorship Guide Provides Nearly 200 Options
2. Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007
3. Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos
4. Paul Sullivans Legacy: An Early Warning Program for Detecting Melanoma Before Its Too Late
5. Husband Seeks Votes for Alzheimers Disease: Early Detection Matters Project
6. U.S. Department of Labor announces $1.2 million grant to provide nearly 700 North Carolina workers with health insurance payments as part of Trade Adjustment Assistance benefits
7. The Market for Disease-Modifying Osteoarthritis Drugs Will Experience Exponential Growth, Increasing From $477 Million in 2007 to Nearly $3.8 Billion in 2017
8. Early Mobility Best for ICU Patients
9. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event
10. Autism Speaks, CDC and The Advertising Council Launch Program to Educate Teachers About Importance of Early Intervention for Autism
11. Early Breast Cancer No More Likely to Return in Young Women
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology: